Europe Immuno-modulatory Biomaterial Market Report 2016

November 2016 | 115 pages | ID: E800EC20559EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Immuno-modulatory Biomaterial

Revenue, means the sales value of Immuno-modulatory Biomaterial

This report studies sales (consumption) of Immuno-modulatory Biomaterial in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• Biomet, Inc. (US)
• Bioventus LLC (US)
• DePuy Synthes Companies (US)
• DePuy Spine, Inc. (US)
• Exactech, Inc. (US)
• Histogenics Corp. (US)
• Integra LifeSciences Holdings Corp (US)
• LifeCell Corporation (US)
• LifeNet Health, Inc. (US)
• Medtronic, Inc. (US)
• NovaBone Products LLC (US)
• NuVasive, Inc. (US)
• Orthofix International N.V. (Netherlands)
• Osiris Therapeutics, Inc. (US)
• Smith & Nephew Plc (UK)
• Stryker Corporation (US)
• TiGenix N.V. (Belgium)
• Wright Medical Technology, Inc. (US)
• BioMimetic Therapeutics LLC (US)
• Zimmer Holdings, Inc. (US)

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Immuno-modulatory Biomaterial in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on sales, market share and growth rate of Immuno-modulatory Biomaterial in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Europe Immuno-modulatory Biomaterial Market Report 2016

1 IMMUNO-MODULATORY BIOMATERIAL OVERVIEW

1.1 Product Overview and Scope of Immuno-modulatory Biomaterial
1.2 Classification of Immuno-modulatory Biomaterial
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Immuno-modulatory Biomaterial
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Immuno-modulatory Biomaterial Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Immuno-modulatory Biomaterial (2011-2021)
  1.5.1 Europe Immuno-modulatory Biomaterial Sales and Growth Rate (2011-2021)
  1.5.2 Europe Immuno-modulatory Biomaterial Revenue and Growth Rate (2011-2021)

2 EUROPE IMMUNO-MODULATORY BIOMATERIAL BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Immuno-modulatory Biomaterial Market Competition by Manufacturers
  2.1.1 Europe Immuno-modulatory Biomaterial Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Immuno-modulatory Biomaterial Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Immuno-modulatory Biomaterial (Volume and Value) by Type
  2.2.1 Europe Immuno-modulatory Biomaterial Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Immuno-modulatory Biomaterial Revenue and Market Share by Type (2011-2016)
2.3 Europe Immuno-modulatory Biomaterial (Volume and Value) by Countries
  2.3.1 Europe Immuno-modulatory Biomaterial Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Immuno-modulatory Biomaterial Revenue and Market Share by Countries (2011-2016)
2.4 Europe Immuno-modulatory Biomaterial (Volume) by Application

3 GERMANY IMMUNO-MODULATORY BIOMATERIAL (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Immuno-modulatory Biomaterial Sales and Value (2011-2016)
  3.1.1 Germany Immuno-modulatory Biomaterial Sales and Growth Rate (2011-2016)
  3.1.2 Germany Immuno-modulatory Biomaterial Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Immuno-modulatory Biomaterial Sales Price Trend (2011-2016)
3.2 Germany Immuno-modulatory Biomaterial Sales and Market Share by Manufacturers
3.3 Germany Immuno-modulatory Biomaterial Sales and Market Share by Type
3.4 Germany Immuno-modulatory Biomaterial Sales and Market Share by Application

4 FRANCE IMMUNO-MODULATORY BIOMATERIAL (VOLUME, VALUE AND SALES PRICE)

4.1 France Immuno-modulatory Biomaterial Sales and Value (2011-2016)
  4.1.1 France Immuno-modulatory Biomaterial Sales and Growth Rate (2011-2016)
  4.1.2 France Immuno-modulatory Biomaterial Revenue and Growth Rate (2011-2016)
  4.1.4 France Immuno-modulatory Biomaterial Sales Price Trend (2011-2016)
4.2 France Immuno-modulatory Biomaterial Sales and Market Share by Manufacturers
4.3 France Immuno-modulatory Biomaterial Sales and Market Share by Type
4.4 France Immuno-modulatory Biomaterial Sales and Market Share by Application

5 UK IMMUNO-MODULATORY BIOMATERIAL (VOLUME, VALUE AND SALES PRICE)

5.1 UK Immuno-modulatory Biomaterial Sales and Value (2011-2016)
  5.1.1 UK Immuno-modulatory Biomaterial Sales and Growth Rate (2011-2016)
  5.1.2 UK Immuno-modulatory Biomaterial Revenue and Growth Rate (2011-2016)
  5.1.5 UK Immuno-modulatory Biomaterial Sales Price Trend (2011-2016)
5.2 UK Immuno-modulatory Biomaterial Sales and Market Share by Manufacturers
5.3 UK Immuno-modulatory Biomaterial Sales and Market Share by Type
5.4 UK Immuno-modulatory Biomaterial Sales and Market Share by Application

6 RUSSIA IMMUNO-MODULATORY BIOMATERIAL (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Immuno-modulatory Biomaterial Sales and Value (2011-2016)
  6.1.1 Russia Immuno-modulatory Biomaterial Sales and Growth Rate (2011-2016)
  6.1.2 Russia Immuno-modulatory Biomaterial Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Immuno-modulatory Biomaterial Sales Price Trend (2011-2016)
6.2 Russia Immuno-modulatory Biomaterial Sales and Market Share by Manufacturers
6.3 Russia Immuno-modulatory Biomaterial Sales and Market Share by Type
6.4 Russia Immuno-modulatory Biomaterial Sales and Market Share by Application

7 ITALY IMMUNO-MODULATORY BIOMATERIAL (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Immuno-modulatory Biomaterial Sales and Value (2011-2016)
  7.1.1 Italy Immuno-modulatory Biomaterial Sales and Growth Rate (2011-2016)
  7.1.2 Italy Immuno-modulatory Biomaterial Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Immuno-modulatory Biomaterial Sales Price Trend (2011-2016)
7.2 Italy Immuno-modulatory Biomaterial Sales and Market Share by Manufacturers
7.3 Italy Immuno-modulatory Biomaterial Sales and Market Share by Type
7.4 Italy Immuno-modulatory Biomaterial Sales and Market Share by Application

8 SPAIN IMMUNO-MODULATORY BIOMATERIAL (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Immuno-modulatory Biomaterial Sales and Value (2011-2016)
  8.1.1 Spain Immuno-modulatory Biomaterial Sales and Growth Rate (2011-2016)
  8.1.2 Spain Immuno-modulatory Biomaterial Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Immuno-modulatory Biomaterial Sales Price Trend (2011-2016)
8.2 Spain Immuno-modulatory Biomaterial Sales and Market Share by Manufacturers
8.3 Spain Immuno-modulatory Biomaterial Sales and Market Share by Type
8.4 Spain Immuno-modulatory Biomaterial Sales and Market Share by Application

9 BENELUX IMMUNO-MODULATORY BIOMATERIAL (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Immuno-modulatory Biomaterial Sales and Value (2011-2016)
  9.1.1 Benelux Immuno-modulatory Biomaterial Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Immuno-modulatory Biomaterial Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Immuno-modulatory Biomaterial Sales Price Trend (2011-2016)
9.2 Benelux Immuno-modulatory Biomaterial Sales and Market Share by Manufacturers
9.3 Benelux Immuno-modulatory Biomaterial Sales and Market Share by Type
9.4 Benelux Immuno-modulatory Biomaterial Sales and Market Share by Application

10 EUROPE IMMUNO-MODULATORY BIOMATERIAL MANUFACTURERS ANALYSIS

10.1 Biomet, Inc. (US)
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Immuno-modulatory Biomaterial Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Biomet, Inc. (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Bioventus LLC (US)
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Immuno-modulatory Biomaterial Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 Bioventus LLC (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 DePuy Synthes Companies (US)
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Immuno-modulatory Biomaterial Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 DePuy Synthes Companies (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 DePuy Spine, Inc. (US)
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Immuno-modulatory Biomaterial Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 DePuy Spine, Inc. (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Exactech, Inc. (US)
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Immuno-modulatory Biomaterial Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Exactech, Inc. (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Histogenics Corp. (US)
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Immuno-modulatory Biomaterial Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 Histogenics Corp. (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Integra LifeSciences Holdings Corp (US)
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Immuno-modulatory Biomaterial Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 Integra LifeSciences Holdings Corp (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 LifeCell Corporation (US)
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Immuno-modulatory Biomaterial Product Type, Application and Specification
    10.8.2.1 Type I
    10.8.2.2 Type II
  10.8.3 LifeCell Corporation (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview
10.9 LifeNet Health, Inc. (US)
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Immuno-modulatory Biomaterial Product Type, Application and Specification
    10.9.2.1 Type I
    10.9.2.2 Type II
  10.9.3 LifeNet Health, Inc. (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Main Business/Business Overview
10.10 Medtronic, Inc. (US)
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Immuno-modulatory Biomaterial Product Type, Application and Specification
    10.10.2.1 Type I
    10.10.2.2 Type II
  10.10.3 Medtronic, Inc. (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
  10.10.4 Main Business/Business Overview
10.11 NovaBone Products LLC (US)
10.12 NuVasive, Inc. (US)
10.13 Orthofix International N.V. (Netherlands)
10.14 Osiris Therapeutics, Inc. (US)
10.15 Smith & Nephew Plc (UK)
10.16 Stryker Corporation (US)
10.17 TiGenix N.V. (Belgium)
10.18 Wright Medical Technology, Inc. (US)
10.19 BioMimetic Therapeutics LLC (US)
10.20 Zimmer Holdings, Inc. (US)

11 IMMUNO-MODULATORY BIOMATERIAL MANUFACTURING COST ANALYSIS

11.1 Immuno-modulatory Biomaterial Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Immuno-modulatory Biomaterial

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Immuno-modulatory Biomaterial Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Immuno-modulatory Biomaterial Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE IMMUNO-MODULATORY BIOMATERIAL MARKET FORECAST (2016-2021)

14.1 Germany Immuno-modulatory Biomaterial Sales Forecast (2016-2021)
14.2 France Immuno-modulatory Biomaterial Sales Forecast (2016-2021)
14.3 UK Immuno-modulatory Biomaterial Sales Forecast (2016-2021)
14.4 Russia Immuno-modulatory Biomaterial Sales Forecast (2016-2021)
14.5 Italy Immuno-modulatory Biomaterial Sales Forecast (2016-2021)
14.6 Spain Immuno-modulatory Biomaterial Sales Forecast (2016-2021)
14.7 Benelux Immuno-modulatory Biomaterial Sales Forecast (2016-2021)
14.8 Europe Immuno-modulatory Biomaterial Sales Forecast by Type (2016-2021)
14.9 Europe Immuno-modulatory Biomaterial Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Immuno-modulatory Biomaterial
Table Classification of Immuno-modulatory Biomaterial
Figure Europe Sales Market Share of Immuno-modulatory Biomaterial by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Immuno-modulatory Biomaterial
Figure Europe Sales Market Share of Immuno-modulatory Biomaterial by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Immuno-modulatory Biomaterial Revenue and Growth Rate (2011-2021)
Figure France Immuno-modulatory Biomaterial Revenue and Growth Rate (2011-2021)
Figure UK Immuno-modulatory Biomaterial Revenue and Growth Rate (2011-2021)
Figure Russia Immuno-modulatory Biomaterial Revenue and Growth Rate (2011-2021)
Figure Italy Immuno-modulatory Biomaterial Revenue and Growth Rate (2011-2021)
Figure Spain Immuno-modulatory Biomaterial Revenue and Growth Rate (2011-2021)
Figure Benelux Immuno-modulatory Biomaterial Revenue and Growth Rate (2011-2021)
Figure Europe Immuno-modulatory Biomaterial Sales and Growth Rate (2011-2021)
Figure Europe Immuno-modulatory Biomaterial Revenue and Growth Rate (2011-2021)
Table Europe Immuno-modulatory Biomaterial Sales of Key Manufacturers (2015 and 2016)
Table Europe Immuno-modulatory Biomaterial Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Immuno-modulatory Biomaterial Sales Share by Manufacturers
Figure 2016 Immuno-modulatory Biomaterial Sales Share by Manufacturers
Table Europe Immuno-modulatory Biomaterial Revenue by Manufacturers (2015 and 2016)
Table Europe Immuno-modulatory Biomaterial Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Immuno-modulatory Biomaterial Revenue Share by Manufacturers
Table 2016 Europe Immuno-modulatory Biomaterial Revenue Share by Manufacturers
Table Europe Immuno-modulatory Biomaterial Sales and Market Share by Type (2011-2016)
Table Europe Immuno-modulatory Biomaterial Sales Share by Type (2011-2016)
Figure Sales Market Share of Immuno-modulatory Biomaterial by Type (2011-2016)
Figure Europe Immuno-modulatory Biomaterial Sales Growth Rate by Type (2011-2016)
Table Europe Immuno-modulatory Biomaterial Revenue and Market Share by Type (2011-2016)
Table Europe Immuno-modulatory Biomaterial Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Immuno-modulatory Biomaterial by Type (2011-2016)
Figure Europe Immuno-modulatory Biomaterial Revenue Growth Rate by Type (2011-2016)
Table Europe Immuno-modulatory Biomaterial Sales and Market Share by Countries (2011-2016)
Table Europe Immuno-modulatory Biomaterial Sales Share by Countries (2011-2016)
Figure Sales Market Share of Immuno-modulatory Biomaterial by Countries (2011-2016)
Table Europe Immuno-modulatory Biomaterial Revenue and Market Share by Countries (2011-2016)
Table Europe Immuno-modulatory Biomaterial Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Immuno-modulatory Biomaterial by Countries (2011-2016)
Table Europe Immuno-modulatory Biomaterial Sales and Market Share by Application (2011-2016)
Table Europe Immuno-modulatory Biomaterial Sales Share by Application (2011-2016)
Figure Sales Market Share of Immuno-modulatory Biomaterial by Application (2011-2016)
Figure Germany Immuno-modulatory Biomaterial Sales and Growth Rate (2011-2016)
Figure Germany Immuno-modulatory Biomaterial Revenue and Growth Rate (2011-2016)
Figure Germany Immuno-modulatory Biomaterial Sales Price Trend (2011-2016)
Table Germany Immuno-modulatory Biomaterial Sales by Manufacturers (2015 and 2016)
Table Germany Immuno-modulatory Biomaterial Market Share by Manufacturers (2015 and 2016)
Table Germany Immuno-modulatory Biomaterial Sales by Type (2015 and 2016)
Table Germany Immuno-modulatory Biomaterial Market Share by Type (2015 and 2016)
Table Germany Immuno-modulatory Biomaterial Sales by Application (2015 and 2016)
Table Germany Immuno-modulatory Biomaterial Market Share by Application (2015 and 2016)
Figure France Immuno-modulatory Biomaterial Sales and Growth Rate (2011-2016)
Figure France Immuno-modulatory Biomaterial Revenue and Growth Rate (2011-2016)
Figure France Immuno-modulatory Biomaterial Sales Price Trend (2011-2016)
Table France Immuno-modulatory Biomaterial Sales by Manufacturers (2015 and 2016)
Table France Immuno-modulatory Biomaterial Market Share by Manufacturers (2015 and 2016)
Table France Immuno-modulatory Biomaterial Sales by Type (2015 and 2016)
Table France Immuno-modulatory Biomaterial Market Share by Type (2015 and 2016)
Table France Immuno-modulatory Biomaterial Sales by Application (2015 and 2016)
Table France Immuno-modulatory Biomaterial Market Share by Application (2015 and 2016)
Figure UK Immuno-modulatory Biomaterial Sales and Growth Rate (2011-2016)
Figure UK Immuno-modulatory Biomaterial Revenue and Growth Rate (2011-2016)
Figure UK Immuno-modulatory Biomaterial Sales Price Trend (2011-2016)
Table UK Immuno-modulatory Biomaterial Sales by Manufacturers (2015 and 2016)
Table UK Immuno-modulatory Biomaterial Market Share by Manufacturers (2015 and 2016)
Table UK Immuno-modulatory Biomaterial Sales by Type (2015 and 2016)
Table UK Immuno-modulatory Biomaterial Market Share by Type (2015 and 2016)
Table UK Immuno-modulatory Biomaterial Sales by Application (2015 and 2016)
Table UK Immuno-modulatory Biomaterial Market Share by Application (2015 and 2016)
Figure Russia Immuno-modulatory Biomaterial Sales and Growth Rate (2011-2016)
Figure Russia Immuno-modulatory Biomaterial Revenue and Growth Rate (2011-2016)
Figure Russia Immuno-modulatory Biomaterial Sales Price Trend (2011-2016)
Table Russia Immuno-modulatory Biomaterial Sales by Manufacturers (2015 and 2016)
Table Russia Immuno-modulatory Biomaterial Market Share by Manufacturers (2015 and 2016)
Table Russia Immuno-modulatory Biomaterial Sales by Type (2015 and 2016)
Table Russia Immuno-modulatory Biomaterial Market Share by Type (2015 and 2016)
Table Russia Immuno-modulatory Biomaterial Sales by Application (2015 and 2016)
Table Russia Immuno-modulatory Biomaterial Market Share by Application (2015 and 2016)
Figure Italy Immuno-modulatory Biomaterial Sales and Growth Rate (2011-2016)
Figure Italy Immuno-modulatory Biomaterial Revenue and Growth Rate (2011-2016)
Figure Italy Immuno-modulatory Biomaterial Sales Price Trend (2011-2016)
Table Italy Immuno-modulatory Biomaterial Sales by Manufacturers (2015 and 2016)
Table Italy Immuno-modulatory Biomaterial Market Share by Manufacturers (2015 and 2016)
Table Italy Immuno-modulatory Biomaterial Sales by Type (2015 and 2016)
Table Italy Immuno-modulatory Biomaterial Market Share by Type (2015 and 2016)
Table Italy Immuno-modulatory Biomaterial Sales by Application (2015 and 2016)
Table Italy Immuno-modulatory Biomaterial Market Share by Application (2015 and 2016)
Figure Spain Immuno-modulatory Biomaterial Sales and Growth Rate (2011-2016)
Figure Spain Immuno-modulatory Biomaterial Revenue and Growth Rate (2011-2016)
Figure Spain Immuno-modulatory Biomaterial Sales Price Trend (2011-2016)
Table Spain Immuno-modulatory Biomaterial Sales by Manufacturers (2015 and 2016)
Table Spain Immuno-modulatory Biomaterial Market Share by Manufacturers (2015 and 2016)
Table Spain Immuno-modulatory Biomaterial Sales by Type (2015 and 2016)
Table Spain Immuno-modulatory Biomaterial Market Share by Type (2015 and 2016)
Table Spain Immuno-modulatory Biomaterial Sales by Application (2015 and 2016)
Table Spain Immuno-modulatory Biomaterial Market Share by Application (2015 and 2016)
Figure Benelux Immuno-modulatory Biomaterial Sales and Growth Rate (2011-2016)
Figure Benelux Immuno-modulatory Biomaterial Revenue and Growth Rate (2011-2016)
Figure Benelux Immuno-modulatory Biomaterial Sales Price Trend (2011-2016)
Table Benelux Immuno-modulatory Biomaterial Sales by Manufacturers (2015 and 2016)
Table Benelux Immuno-modulatory Biomaterial Market Share by Manufacturers (2015 and 2016)
Table Benelux Immuno-modulatory Biomaterial Sales by Type (2015 and 2016)
Table Benelux Immuno-modulatory Biomaterial Market Share by Type (2015 and 2016)
Table Benelux Immuno-modulatory Biomaterial Sales by Application (2015 and 2016)
Table Benelux Immuno-modulatory Biomaterial Market Share by Application (2015 and 2016)
Table Immuno-modulatory Biomaterial Basic Information List
Table Biomet, Inc. (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Biomet, Inc. (US) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table Bioventus LLC (US) Basic Information List
Table Bioventus LLC (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bioventus LLC (US) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table DePuy Synthes Companies (US) Basic Information List
Table DePuy Synthes Companies (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table DePuy Synthes Companies (US) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table DePuy Spine, Inc. (US) Basic Information List
Table DePuy Spine, Inc. (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table DePuy Spine, Inc. (US) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table Exactech, Inc. (US) Basic Information List
Table Exactech, Inc. (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table Exactech, Inc. (US) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table Histogenics Corp. (US) Basic Information List
Table Histogenics Corp. (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table Histogenics Corp. (US) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table Integra LifeSciences Holdings Corp (US) Basic Information List
Table Integra LifeSciences Holdings Corp (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table Integra LifeSciences Holdings Corp (US) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table LifeCell Corporation (US) Basic Information List
Table LifeCell Corporation (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table LifeCell Corporation (US) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table LifeNet Health, Inc. (US) Basic Information List
Table LifeNet Health, Inc. (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table LifeNet Health, Inc. (US) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table Medtronic, Inc. (US) Basic Information List
Table Medtronic, Inc. (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table Medtronic, Inc. (US) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table NovaBone Products LLC (US) Basic Information List
Table NovaBone Products LLC (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table NovaBone Products LLC (US) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table NuVasive, Inc. (US) Basic Information List
Table NuVasive, Inc. (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table NuVasive, Inc. (US) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table Orthofix International N.V. (Netherlands) Basic Information List
Table Orthofix International N.V. (Netherlands) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table Orthofix International N.V. (Netherlands) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table Osiris Therapeutics, Inc. (US) Basic Information List
Table Osiris Therapeutics, Inc. (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table Osiris Therapeutics, Inc. (US) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table Smith & Nephew Plc (UK) Basic Information List
Table Smith & Nephew Plc (UK) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table Smith & Nephew Plc (UK) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table Stryker Corporation (US) Basic Information List
Table Stryker Corporation (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table Stryker Corporation (US) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table TiGenix N.V. (Belgium) Basic Information List
Table TiGenix N.V. (Belgium) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table TiGenix N.V. (Belgium) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table Wright Medical Technology, Inc. (US) Basic Information List
Table Wright Medical Technology, Inc. (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table Wright Medical Technology, Inc. (US) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table BioMimetic Therapeutics LLC (US) Basic Information List
Table BioMimetic Therapeutics LLC (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table BioMimetic Therapeutics LLC (US) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table Zimmer Holdings, Inc. (US) Basic Information List
Table Zimmer Holdings, Inc. (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table Zimmer Holdings, Inc. (US) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Immuno-modulatory Biomaterial
Figure Manufacturing Process Analysis of Immuno-modulatory Biomaterial
Figure Immuno-modulatory Biomaterial Industrial Chain Analysis
Table Raw Materials Sources of Immuno-modulatory Biomaterial Major Manufacturers in 2015
Table Major Buyers of Immuno-modulatory Biomaterial
Table Distributors/Traders List
Figure Germany Immuno-modulatory Biomaterial Sales and Growth Rate Forecast (2016-2021)
Figure Germany Immuno-modulatory Biomaterial Revenue and Growth Rate Forecast (2016-2021)
Figure France Immuno-modulatory Biomaterial Sales and Growth Rate Forecast (2016-2021)
Figure France Immuno-modulatory Biomaterial Revenue and Growth Rate Forecast (2016-2021)
Figure UK Immuno-modulatory Biomaterial Sales and Growth Rate Forecast (2016-2021)
Figure UK Immuno-modulatory Biomaterial Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Immuno-modulatory Biomaterial Sales and Growth Rate Forecast (2016-2021)
Figure Russia Immuno-modulatory Biomaterial Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Immuno-modulatory Biomaterial Sales and Growth Rate Forecast (2016-2021)
Figure Italy Immuno-modulatory Biomaterial Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Immuno-modulatory Biomaterial Sales and Growth Rate Forecast (2016-2021)
Figure Spain Immuno-modulatory Biomaterial Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Immuno-modulatory Biomaterial Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Immuno-modulatory Biomaterial Revenue and Growth Rate Forecast (2016-2021)
Table Europe Immuno-modulatory Biomaterial Sales Forecast by Type (2016-2021)
Table Europe Immuno-modulatory Biomaterial Sales Forecast by Application (2016-2021)